Efficacy and Safety of Drug-Eluting Stents in Chronic Total Coronary Occlusion Recanalization. A Systematic Review and Meta-Analysis

Journal of the American College of Cardiology

Volumn 55, Issue 17, 2010, Pages 1854-1866

  Colmenarez, Humberto J ^a   Escaned, Javier ^a   Fernández, Cristina ^a   Lobo, Liliana ^a   Cano, Sara ^a   del Angel, Juan G ^a   Alfonso, Fernando ^a   Jimenez, Pilar ^a   Bañuelos, Camino ^a   Gonzalo, Nieves ^a   García, Eulogio ^a   Hernández, Rosana ^a   Macaya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

chronic total occlusion; drug eluting stent; meta analysis; stent

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANGIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; LONG TERM CARE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RESTENOSIS; REVASCULARIZATION; RISK BENEFIT ANALYSIS; SAFETY; STENT THROMBOSIS; SYSTEMATIC REVIEW;

CORONARY OCCLUSION; DRUG-ELUTING STENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; STENTS;

EID: 77950891441     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.038     Document Type: Article

References (31)

1. Grantham A., Marso S.P., Spertus J., et al. Chronic total occlusion angioplasty in the United States. J Am Coll Cardiol Intv 2 (2009) 479-486
2. Carlsson J., James S.K., Lindback J., et al. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. J Am Coll Cardiol 53 (2009) 1389-1398
3. Cutlip D.E., Windecker S., Mehran R., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007) 2344-2351
4. Higgins J.P.T., and Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 (updated September 2008). The Cochrane Collaboration, 2008. www.cochrane-handbook.org Accessed September 1, 2009
5. Wells G., Shea B., O'Connell D., et al. The New Castle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. htpp://www.ohri.ca/programs/clinical_epidemiology/oxford.htm Accessed January 1, 2008
6. Kim K., Kim Y.-.H., Lee B.-.K., et al. Comparison of the effectiveness of drug-eluting-stent versus bare-metal-stent implantation for chronic total occlusion (abstr). Am J Cardiol 94 Suppl 6A (2004) 97E
7. Ge L., Iakovou I., Cosgrave J., et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 26 (2005) 1056-1062
8. Nakamura S., Muthusamy T.S., Bae J.H., Cahyadi Y.H., Udayachalerm W., and Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 95 (2005) 161-166
9. Migliorini A., Moschi G., Vergara R., Parodi G., Carrabba N., and Antoniucci D. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 67 (2006) 344-348
10. Kelbæk H., Helqvist S., Thuesen L., et al. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial. Am Heart J 152 (2006) 882-886
11. Suttorp M.J., Laarman G.J., Rahel B.M., et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 114 (2006) 921-928
12. Werner G.S., Ferrari M., Fritzenwanger M., Betge S., and Figulla H.R. Long-term safety and efficacy of paclitaxel-eluting stent in chronic total coronary occlusions: 3 year of follow-up from paclitaxel in chronic total occlusion (PACTO) study (abstr). Eur Heart J 28 Suppl 1 (2007) 135
13. Garcia-Garcia H.M., Daemen J., Kukreja N., et al. Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital-(RESEARCH) registry. Catheter Cardiovasc Interv 70 (2007) 635-639
14. Aleksiadi E.R., and Shaburishvili TSh. [Comparison between bare metal stents and drug eluting stents for the treatment of chronic total occlusion.]. Georgian Med News (2007) 148-149 10-2
15. Obunai K., Cosmo G., Bassanelli G., et al. Clinical and angiographic outcome after percutaneous revascularization of chronic total occlusion with bare-metal and drug-eluting stent: 3 year follow-up results from an international multicenter CTO registry (abstr). Circulation 118 (2008) S-736
16. La Spina C., Moretti C., Sciuto F., et al. Treatment of chronic total occlusions: long-term safety and efficacy of drug-eluting stent versus bare-metal stent (abstr). EuroIntervention 5 Suppl E (2009) E111
17. De Felice F., Fiorilli R., Parma A., et al. Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. Int J Cardiol 132 (2009) 337-341
18. Han Y.L., Zhang J., Li Y., et al. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions. Chin Med J 122 (2009) 643-647
19. Kandzari D.E., Rao S.V., Moses J.W., et al., ACROSS/TOSCA-4 Investigators. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) Trial. J Am Coll Cardiol Intv 2 (2009) 97-106
20. Rahel B.M., Laarman G.J., Kelder J.C., Ten Berg J.M., and Suttorp M.J. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries PRISON II study). Am Heart J 157 (2009) 149-155
21. Buller C.E., Dzavik V., Carere R.G., et al. Primary stenting versus balloon-angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 100 (1999) 236-242
22. Stone G.W., Reifart N.J., Moussa I., et al. Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. Circulation 112 (2005) 2364-2372
23. Di Mario C., Werner G., Sianos G., et al. European perspective in the recanalisation of chronic total occlusion: consensus document from the Euro-CTO Club. EuroInterv 3 (2007) 30-43
24. Rubartelli P., Niccoli L., Verna E., et al. Stent implantation versus balloon-angioplasty in chronic coronary occlusions: results from the GISSOC Trial. J Am Coll Cardiol 32 (1998) 90-96
25. Alfonso F. The "vulnerable" stent why so dreadful? (letter). J Am Coll Cardiol 51 (2008) 2403-2406
26. Azzarelli S., Amico F., Galassi A.R., Giacoppo M., Argentino V., and Fiscella A. Two-year clinical follow up of coronary drug-eluting stent inpatients at high risk for coronary restenosis. J Invasive Cardiol 20 (2008) 62-66
27. Ko D.T., Chiu M., Guo H., et al. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications. J Am Coll Cardiol 53 (2009) 1773-1782
28. Werner G.S., Bahrmann P., Mutschke O., et al. Determinants of target vessel failure in chronic total coronary occlusions after stent implantation. The influence of collateral function and coronary hemodynamics. J Am Coll Cardiol 16; (2003) 42 219-25
29. ten Berg J.M., Kelder J.C., Suttorp M.J., Verheugt F.W., and Thijs Plokker H.W. Influence of planned six-month follow-up angiography on late outcome after percutaneous coronary intervention: a randomized study. J Am Coll Cardiol 38 (2001) 1061-1069
30. Werner G.S., Moehlis H., and Tischer K. Management of total restenotic occlusions. EuroIntervention 5 Suppl D (2009) D79-D83
31. Win H.K., Caldera A.E., Maresh K., et al., EVENT Registry Investigators. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009